$115,000–$125,000/yr
US
Unlimited PTO
- Lead end-to-end biosample and biomarker operations for Phase 1 SAD/MAD and Phase 2 clinical studies, as well as earlier-stage translational work.
- Develop reusable SOPs, tracking tools, and reconciliation workflows to scale operations across the portfolio.
- Proactively manage risks and maintain tight coordination across R&D, CMC, and external partners.